Brief: Galmed Announces Grant Of New Patent For The Combination Of Aramchol With Resmetirom For The Treatment Of NASH And Liver Fibrosis

Eocene

15/03/2024 13:12

March 15 (Reuters) - Galmed Pharmaceuticals Ltd
 GLMD.O :
    * GALMED ANNOUNCES GRANT OF NEW PATENT FOR THE COMBINATION
OF
ARAMCHOL WITH RESMETIROM (MGL-3196, REZDIFFRA) FOR THE TREATMENT
OF NASH AND LIVER FIBROSIS
    * GALMED PHARMACEUTICALS LTD - GALMED IS STRENGTHENING AND
EXTENDING PATENT PROTECTION OF ITS LEAD COMPOUND, ARAMCHOL,
UNTIL SEPTEMBER 2039
    * GALMED PHARMACEUTICALS LTD - PATENT WAS GRANTED IN FRANCE,
GERMANY, ITALY, NETHERLANDS AND UNITED KINGDOM

Source text for Eikon:  ID:nPnc1Jm2Fa 
Further company coverage:  GLMD.O 

 ((reuters.briefs@thomsonreuters.com;))